IRX15-L Antibody

What is IRX15-L and why is it important in plant cell wall research?

IRX15-L is one of ten genes in the Arabidopsis genome that contain a DUF579 domain. It functions redundantly with its paralog IRX15 in xylan biosynthesis, which is the principal hemicellulose in secondary cell walls of eudicots and in both primary and secondary cell walls of grasses and cereals . IRX15-L is essential for normal xylan deposition in secondary cell walls, making it a critical target for understanding plant cell wall formation mechanisms . While single mutants show minimal phenotypic changes, the irx15 irx15-L double mutant displays reduced stem xylose content and irregular secondary cell wall margins, indicating their functional redundancy and importance in xylan biosynthesis .

How is IRX15-L protein localized within plant cells?

Localization studies using fluorescent fusion proteins have shown that IRX15-L localizes to both the Golgi apparatus and an additional unknown intracellular compartment . This dual localization pattern differs from some other xylan biosynthesis proteins and suggests a potentially unique role in the xylan biosynthetic pathway or deposition process . Understanding this localization is crucial for interpreting antibody staining results in immunohistochemistry experiments.

How does IRX15-L function differ from other xylan biosynthesis proteins?

Unlike glycosyltransferases (GTs) such as IRX9 and IRX10 that directly synthesize the xylan backbone, IRX15-L appears to play a role in xylan deposition or organization rather than in direct synthesis . The irx15 irx15-L double mutant produces a homodisperse, highly methylated xylan with reduced degree of polymerization, similar to irx9 and irx10 mutants, but with distinctly disorganized cell walls as revealed by transmission electron microscopy (TEM) . This suggests IRX15-L may function in a separate aspect of the xylan biosynthetic pathway compared to characterized glycosyltransferases.

What are the key considerations when designing immunolocalization experiments using IRX15-L antibodies?

When designing immunolocalization experiments with IRX15-L antibodies, researchers should consider:

• Fixation protocol: Due to IRX15-L's dual localization in the Golgi and an unknown compartment, optimal fixation methods that preserve endomembrane integrity are essential.

• Control experiments: Include the irx15-L mutant as a negative control to verify antibody specificity.

• Co-localization markers: Use known Golgi markers to confirm the partial Golgi localization observed with fluorescent fusion proteins .

• Cell type specificity: IRX15-L expression is particularly high in cells undergoing secondary wall formation, so tissue selection is critical .

• Cross-reactivity: Consider potential cross-reactivity with the highly similar IRX15 protein when interpreting results.

How can IRX15-L antibodies be used to investigate xylan biosynthesis in non-model plant species?

For non-model plant species, researchers should:

• Evaluate sequence conservation: Check sequence homology between the target species' IRX15-L homolog and Arabidopsis IRX15-L to determine antibody compatibility.

• Perform Western blot validation: Confirm antibody cross-reactivity with the non-model species protein.

• Compare expression patterns: Analyze if IRX15-L expression in the non-model species correlates with tissues actively synthesizing xylan, such as in the psyllium seed mucilaginous layer which produces large amounts of heteroxylan .

• Combine with histochemical staining: Use xylan-specific stains like CBM35 (which binds to GlcA but not 4-O-methyl-GlcA) alongside antibody labeling to correlate IRX15-L presence with xylan deposition patterns .

What tissue preparation methods are optimal for IRX15-L immunohistochemistry in woody plant samples?

For woody plant samples, consider:

• Section thickness: Thinner sections (5-10 μm) improve antibody penetration in lignified tissues.

• Antigen retrieval: Heat or enzymatic pretreatment may be necessary to expose epitopes masked by lignin or other cell wall components.

• Blocking procedures: Extended blocking (2-3 hours) with appropriate agents to prevent non-specific binding in complex woody tissues.

• Comparison with transmission electron microscopy: TEM analysis alongside immunolabeling can reveal cell wall disorganization patterns similar to those observed in Arabidopsis irx15 irx15-L mutants .

How can IRX15-L antibodies be utilized to study the temporal dynamics of xylan deposition during cell wall formation?

To study temporal dynamics, researchers can:

• Design time-course experiments sampling key developmental stages of secondary wall formation.

• Combine IRX15-L immunolabeling with pulse-chase experiments to track newly synthesized xylan.

• Implement dual-labeling protocols with antibodies against IRX15-L and other xylan biosynthesis proteins to establish sequential activities.

• Correlate antibody signal intensity with quantitative measurements of xylan content and degree of polymerization at different developmental stages .

This approach can help resolve whether IRX15-L functions early in xylan biosynthesis initialization or later in deposition and organization processes, clarifying its precise role in the biosynthetic pathway.

What techniques can be combined with IRX15-L immunoprecipitation to identify interacting proteins in the xylan biosynthetic complex?

To identify protein interactions:

• Co-immunoprecipitation coupled with mass spectrometry: Use IRX15-L antibodies to pull down protein complexes, followed by MS analysis to identify interaction partners.

• Proximity labeling approaches: Combine with BioID or APEX2 techniques to capture transient interactions in the native cellular environment.

• Sequential immunoprecipitation: Perform sequential pull-downs with antibodies against known xylan biosynthesis components (like IRX9, IRX10, and IRX15-L) to define subcomplexes.

• Crosslinking mass spectrometry: Implement chemical crosslinking before immunoprecipitation to stabilize weak or transient interactions within the biosynthetic complex.

These approaches could help determine if IRX15-L interacts directly with glycosyltransferases or functions in a separate complex that coordinates with the core xylan synthetic machinery .

How can IRX15-L antibodies contribute to understanding the relationship between xylan structure and cell wall digestibility?

IRX15-L antibodies can help investigate the link between xylan structure and digestibility by:

• Immunolabeling patterns: Compare antibody labeling patterns between wild-type and irx15 irx15-L double mutants, which show dramatic increases in sugar release during cell wall digestibility assays .

• Co-localization with cell wall hydrolases: Study the accessibility of cell wall-degrading enzymes in relation to IRX15-L-dependent xylan organization.

• Temporal correlation: Track changes in IRX15-L distribution alongside measurements of methylglucuronic acid content, as irx15 irx15-L mutants show replacement of glucuronic acid side chains with methylglucuronic acid .

This research direction is particularly valuable for bioenergy applications, as the disorganized walls of irx15 irx15-L mutants exhibit enhanced digestibility despite only moderate reductions in xylose content .

What are common challenges and solutions when working with IRX15-L antibodies in immunoblotting applications?

Common challenges include:

• Cross-reactivity with IRX15: Due to the high similarity between IRX15 and IRX15-L (they function redundantly), antibodies may recognize both proteins . Solution: Use recombinant protein competition assays to determine specificity or test antibodies on protein extracts from irx15 and irx15-L single mutants.

• Low abundance detection: IRX15-L may be expressed at low levels. Solution: Implement enrichment strategies such as subcellular fractionation to concentrate Golgi and endomembrane compartments before immunoblotting.

• Post-translational modifications: If IRX15-L undergoes post-translational modifications, antibody recognition may be affected. Solution: Use multiple antibodies targeting different epitopes or denaturing conditions that normalize epitope exposure.

• Size verification: Confirm that detected bands match the predicted molecular weight of IRX15-L (~40-45 kDa for Arabidopsis), accounting for potential glycosylation or other modifications.

How can researchers differentiate between IRX15 and IRX15-L proteins using immunological approaches?

To differentiate between these highly similar proteins:

• Epitope selection: Design antibodies targeting unique regions that differ between IRX15 and IRX15-L.

• Validation strategy: Test antibody specificity against recombinant IRX15 and IRX15-L proteins.

• Mutant analysis: Validate antibody specificity using protein extracts from irx15 and irx15-L single mutants.

• Isoform-specific immunoprecipitation: Perform sequential immunoprecipitation with general and specific antibodies to deplete one isoform before detecting the other.

This differentiation is crucial as the proteins function redundantly but may have subtle differences in localization or interaction partners that could reveal their precise roles in xylan biosynthesis .

What controls are essential when validating a new IRX15-L antibody for research applications?

Essential controls include:

• Genetic controls: Test antibody reactivity in wild-type, irx15-L single mutant, and irx15 irx15-L double mutant samples to verify specificity.

• Peptide competition: Pre-incubate antibody with the peptide used for immunization to confirm epitope-specific binding.

• Recombinant protein controls: Test against purified recombinant IRX15-L protein and related DUF579-containing proteins.

• Cross-species validation: Verify reactivity against IRX15-L homologs from different plant species if cross-species use is intended.

• Subcellular localization comparison: Confirm that antibody labeling matches the Golgi and unknown compartment localization pattern observed with fluorescent fusion proteins .

How might IRX15-L antibodies contribute to understanding the evolution of xylan biosynthesis across plant lineages?

IRX15-L antibodies could facilitate evolutionary studies by:

• Comparative immunolocalization: Apply validated antibodies across diverse plant species to track conservation of IRX15-L localization patterns.

• Correlation with xylan structures: Compare IRX15-L distribution patterns with characterized xylan structures in different species (e.g., psyllium complex heteroxylan vs. Arabidopsis glucuronoxylan) .

• Developmental timing analysis: Investigate whether IRX15-L expression timing relative to other xylan biosynthetic enzymes is conserved across species.

• Co-evolution studies: Use immunoprecipitation to identify interacting partners across species and trace the evolution of the xylan biosynthetic complex.

Such comparative approaches could reveal how the DUF579 domain's function has evolved and whether IRX15-L's role in xylan organization is a conserved or derived trait in land plants.

What is the potential for using IRX15-L antibodies to study the coordination between xylan biosynthesis and other cell wall components?

IRX15-L antibodies could help investigate coordination mechanisms by:

• Dual immunolabeling: Perform co-localization studies with antibodies against IRX15-L and components of cellulose or lignin biosynthetic machinery.

• Temporal correlation: Track the timing of IRX15-L appearance relative to cellulose synthase complexes and lignification.

• Perturbation studies: Examine changes in IRX15-L distribution when other cell wall biosynthetic pathways are disrupted.

• Protein complex analysis: Use IRX15-L antibodies in blue native PAGE or co-immunoprecipitation to identify associations with machinery for other cell wall components.

This research direction would address whether the disorganized wall phenotype in irx15 irx15-L mutants results from direct effects on xylan or from disrupted coordination with other wall components.

How can IRX15-L antibodies help investigate the functional differences between DUF579 family members in plants?

The Arabidopsis genome contains 10 genes encoding DUF579 domain-containing proteins, with 5 co-expressed with secondary cell wall formation markers . IRX15-L antibodies could help differentiate their functions by:

• Comparative localization: Map the distribution of different DUF579 family members using specific antibodies.

• Expression domain analysis: Compare tissue-specific expression patterns of different family members through immunohistochemistry.

• Sequential action investigation: Determine whether different DUF579 proteins act sequentially or in parallel pathways through co-localization studies.

• Structure-function analysis: Correlate antibody epitope accessibility with protein function across the family.

This approach could clarify why some DUF579 family members (like GXMT1) may function as O-methyltransferases while IRX15 and IRX15-L appear to have different roles in xylan biosynthesis despite sequence similarities .